Law & policy

Latest content

As the US mid-term elections near, some wonder whether the Senate’s IP sub-committee will survive

With the retirement of Patrick Leahy and the overall race too close to call, uncertainty is the name of the game in Washington DC

14 September 2022

Vidal’s take on discretionary denials breathes fresh air into PTAB

Saturday Opinion: The new USPTO director is doing what Congress intended the America Invents Act to do with the post-grant invalidity challenge system it created

10 September 2022

Asia, US IP office leaders look to keep apace with AI and NFTs

Patent bodies must adapt and evolve to address knowledge gaps in changing digital landscape

09 September 2022

Chinese Supreme Court’s first patent linkage ruling is a mixed bag

The top court speedily backed an earlier judgment against rights owner Chugai Pharmaceuticals

08 September 2022

USPTO director seeks to drive US patent standards participation

Kathi Vidal says the agency is working with NIST and the Biden administration to build strategies that will lead to greater involvement

07 September 2022

Why the United States urgently needs patent subject-matter eligibility reform

The law is in a state of disarray that has led to inconsistent case decisions, deep uncertainty in the innovative, investment and legal communities, and unpredictable outcomes in prosecution and litigation. David Kappos, Paul Michel, Corey Salsberg and Matthew Dowd argue that the United States' legislators must act to ensure the country maintains its long-standing competitive edge in the global innovation race

07 September 2022

An unwelcome bend in jurisprudence for patent composition claims?

A recent judgment from the Delhi High Court emphasises procedural irregularities and denial of principles of natural justice resulting from the controller issuing a non-speaking order in a case involving non-patentable subject matter.

07 September 2022

Nokia/Oppo dispute to provide interesting test of new German injunction rules

The Chinese handset maker is seeking to shut down the Finnish company’s base stations

05 September 2022

Moderna is likely regretting its covid-19 patent pledge

The company’s October 2020 non-enforcement promise may be a roadblock for its legal action against Pfizer/BioNTech

03 September 2022

The dangers of patent counting to assess technology leadership

Former USPTO Director Andrei Iancu warns that the US is facing “a new Sputnik moment”, but he and others at an online event caution against reading too much into raw numbers

01 September 2022

Unlock unlimited access to all IAM content